3-(2,4-dimethoxybenzylidene)anabaseine and Disease Exacerbation

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Amrani, Y; Boubakeur, M; Derrar, F; Djidjik, R; Douaoui, S; Ghernaout, M; Oumouna, M; Touil-Boukoffa, C	1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Disease Exacerbation

Article	Year
GTS-21, an α7nAChR agonist, suppressed the production of key inflammatory mediators by PBMCs that are elevated in COPD patients and associated with impaired lung function. Immunobiology, 2020, Volume: 225, Issue:3 Topics: Aged; alpha7 Nicotinic Acetylcholine Receptor; Benzylidene Compounds; Biomarkers; Cytokines; Disease Progression; Female; Humans; Inflammation Mediators; Leukocytes, Mononuclear; Male; Middle Aged; Nitric Oxide; Pulmonary Disease, Chronic Obstructive; Pyridines; Respiratory Function Tests	2020

Article

Year

GTS-21, an α7nAChR agonist, suppressed the production of key inflammatory mediators by PBMCs that are elevated in COPD patients and associated with impaired lung function.

Immunobiology, 2020, Volume: 225, Issue:3

Topics: Aged; alpha7 Nicotinic Acetylcholine Receptor; Benzylidene Compounds; Biomarkers; Cytokines; Disease Progression; Female; Humans; Inflammation Mediators; Leukocytes, Mononuclear; Male; Middle Aged; Nitric Oxide; Pulmonary Disease, Chronic Obstructive; Pyridines; Respiratory Function Tests

2020